发明名称 |
Anti cancer vaccine comprising whole cancer cells with modified sialic acid |
摘要 |
<p>When tumor cells are incubated with N-propionyl mannosamine, the N-acetyl groups of their surface a2-8 polysialic acid are converted to N-propionyl groups. The resultant bio-engineered cancer cells can be killed and used as a allogenic or autologous therapy or vaccine. The presence of N-propionylated polysialic acid-specific antibodies is detected in animals immunized with the vaccine prior to tumor implantation. Mice immunized with the heat-killed cancer cells experience better protection against challenge with live autologous RMA-S cells than mice immunized with heat-killed autologous RMA-S cells. Killed cells having modified sialic acid groups on their surface may be used as an anti-cancer therapy or vaccine either alone or in combination with an anti-cancer compound, such as cyclophosphamide. <IMAGE> <IMAGE></p> |
申请公布号 |
EP1293212(A1) |
申请公布日期 |
2003.03.19 |
申请号 |
EP20020255834 |
申请日期 |
2002.08.21 |
申请人 |
NATIONAL RESEARCH COUNCIL OF CANADA |
发明人 |
JENNINGS, HAROLD J.;LIU, TIANMIN;YANG, QINGLING |
分类号 |
A61K39/00;A61P35/00;C12N5/09;(IPC1-7):A61K39/00 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|